The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1844K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Betz, U. A.K.
Right arrow Articles by Müller, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Betz, U. A.K.
Right arrow Articles by Müller, W.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/11/1955/ $5.00
The Journal of Experimental Medicine, Volume 188, Number 10, November 16, 1998 1955-1965


Articles

Postnatally Induced Inactivation of gp130 in Mice Results in Neurological, Cardiac, Hematopoietic, Immunological, Hepatic, and Pulmonary Defects

Ulrich A.K. Betz*, Wilhelm Bloch{ddagger}, Maries van den Broek§, Kanji Yoshida||, Tetsuya Taga**, Tadamitsu Kishimoto, Klaus Addicks{ddagger}, Klaus Rajewsky*, and Werner Müller*

From the * Institute for Genetics and the {ddagger} Institute for Anatomy I, University of Cologne, D-50931 Cologne, Germany; the § Institute for Experimental Immunology, University of Zürich, CH-8093 Zürich, Switzerland; the || Department of Molecular Immunology, Research Institute for Microbial Diseases, and the Department of Medicine III, Medical School, Osaka University, Osaka 565, Japan; and the ** Department of Molecular Cell Biology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 101, Japan

The pleiotrophic but overlapping functions of the cytokine family that includes interleukin (IL)-6, IL-11, leukemia inhibitory factor, oncostatin M, ciliary neurotrophic factor, and cardiotrophin 1 are mediated by the cytokine receptor subunit gp130 as the common signal transducer. Although mice lacking individual members of this family display only mild phenotypes, animals lacking gp130 are not viable. To assess the collective role of this cytokine family, we inducibly inactivated gp130 via Cre-loxP–mediated recombination in vivo. Such conditional mutant mice exhibited neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects, demonstrating the widespread importance of gp130-dependent cytokines.

Key Words: gene targeting • conditional gene targeting • Cre/loxP technology • gp130-dependent cytokines • gp130


Address correspondence to Werner Müller, Institute for Genetics, Weyertal 121, D-50931 Cologne, Germany. Fax: 49-221-470-5185; E-mail: w.mueller{at}uni-koeln.de

U.A.K. Betz's present address is Pharma Research Antiinfectives, Bayer AG, D-42096 Wuppertal, Germany.

Abbreviations used: APP, acute phase protein(s); CNTF, ciliary neurotrophic factor; CT-1, cardiotrophin 1; JAK, Janus kinase; LIF, leukemia inhibitory factor; MAPK, mitogen-activated protein kinase; OSM, oncostatin M; s, soluble; SAP, serum amyloid P; STAT, signal transducer and activator of transcription; VSV, vesicular stomatitis virus.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS